|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.020 USD | +4.16% |
|
+4.52% | -14.10% |
| 07-16 | Moderna advances its cancer therapy assessment, but the stock slides |  |
| 06-01 | Immatics N.V. Announces Updated Clinical Data For IMA203CD8, IMA401, And Anzu-Cel PRAME Cell Therapies | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.16% | +4.52% | -9.35% | -16.40% | -14.10% | +39.20% | -28.53% | -24.83% | - | 1.23B | |
| +0.05% | +3.08% | +3.53% | +17.30% | +41.77% | +38.17% | +66.77% | -19.12% | - | 56.7B | |
| +0.42% | -6.06% | -10.80% | +5.96% | +1.17% | +23.42% | +62.02% | +174.18% | +5,526.07% | 51.97B | |
| +1.84% | +1.27% | -5.43% | -5.42% | -3.10% | -14.06% | -13.50% | -73.78% | - | 23.33B | |
| -0.15% | -6.00% | -11.78% | -26.12% | -43.43% | -9.42% | +344.47% | +309.53% | +737.87% | 21.34B | |
| +2.23% | -1.18% | +3.17% | +10.42% | -6.98% | +33.35% | -25.50% | -35.65% | +53.54% | 17.44B | |
| +9.91% | -2.51% | -7.36% | +95.51% | +174.96% | +188.84% | +326.19% | +1,430.54% | +654.80% | 14.77B | |
| +3.83% | -1.34% | -1.41% | +26.05% | +25.62% | +47.77% | +165.22% | +224.45% | +486.37% | 13.84B | |
| +1.61% | +0.56% | +2.41% | +14.97% | +29.55% | +439.92% | +166.12% | +28.85% | +1,360.27% | 12.12B | |
| +3.14% | -12.56% | -8.73% | -6.17% | -17.23% | +59.51% | +149.39% | +464.47% | +6,040.13% | 11.14B | |
| -0.88% | -5.17% | -11.61% | +20.68% | +20.32% | +108.37% | +141.17% | +165.18% | +531.82% | 10.38B | |
| +0.19% | -0.46% | -15.40% | -19.05% | -25.41% | -51.81% | +565.56% | +63.68% | +86.40% | 10.41B | |
| +0.29% | -0.11% | +98.34% | +114.66% | +79.94% | +200.86% | +336.25% | +372.95% | - | 8.83B | |
| -3.46% | -5.11% | +9.58% | +36.75% | +189.77% | +483.83% | +628.69% | -39.44% | -17.81% | 8.35B | |
| -1.02% | -3.55% | -8.32% | -5.97% | +16.02% | +62.11% | +9.65% | +139.51% | - | 7.73B | |
| -0.28% | +2.29% | -24.26% | +0.56% | +261.11% | +201.69% | +238.06% | -36.56% | - | 7.49B | |
| -4.78% | -12.64% | -19.10% | +14.34% | +1.66% | +7.51% | +340.07% | +277.07% | - | 7.05B | |
| -1.17% | -2.42% | -0.54% | +17.03% | +7.13% | +10.36% | +66.44% | +9.44% | +207.02% | 7.26B | |
| -0.18% | -3.91% | +0.44% | +6.09% | +9.40% | +240.88% | +221.16% | +521.76% | - | 6.64B | |
| -1.47% | -5.74% | -11.28% | -31.95% | -50.27% | - | - | - | - | 6.41B | |
| Average | +0.40% | -2.14% | -1.40% | +13.46% | +34.90% | +111.08% | +197.88% | +208.01% | +1,424.23% | 15.22B | |
| Weighted average by Cap. | +0.55% | -2.10% | -2.23% | +13.16% | +27.97% | +77.32% | +154.77% | +179.84% | +2,300.41% |
- Stock Market
- Stocks
- IMTX Stock
- Sector Immatics N.V.
Select your edition
All financial news and data tailored to specific country editions
